David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Cambridge Quarterly of Healthcare Ethics 13 (04):319-326 (2004)
Due to modern biochemistry and, in particular, recent developments in genomics, proteomics, and bioinformatics, human samples have become the most important raw materials for advancement in the health sciences. Such material has been at the center of fundamental biomedical research for a long time. What is new is its increased usefulness in research with direct clinical relevance, such as the development of drugs. Because of the larger commercial involvement in such research, this has also led to greater economic interests in human biological material and in the information that can be extracted from it
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Jane Kaye (ed.) (2012). Governing Biobanks: Understanding the Interplay Between Law and Practice. Hart Pub..
Gerard Porter (2009). Biobanks in Japan : Ethics, Guidelines and Practice. In Margaret Sleeboom-Faulkner (ed.), Human Genetic Biobanks in Asia: Politics of Trust and Scientific Advancement. Routledge
Jean V. McHale (2011). Accountability, Governance and Biobanks: The Ethics and Governance Committee as Guardian or as Toothless Tiger? [REVIEW] Health Care Analysis 19 (3):231-246.
Ma'N. H. Zawati & Amélie Rioux (2011). Biobanks and the Return of Research Results: Out with the Old and In with the New? Journal of Law, Medicine & Ethics 39 (4):614-620.
Mairi Levitt (2011). Relating to Participants: How Close Do Biobanks and Donors Really Want to Be? [REVIEW] Health Care Analysis 19 (3):220-230.
Mats Hansson (2012). Where Should We Draw the Line Between Quality of Care and Other Ethical Concerns Related to Medical Registries and Biobanks? Theoretical Medicine and Bioethics 33 (4):313-323.
Tohru Masui (2009). Trust and the Creation of Biobanks : Biobanking in Japan and the UK. In Margaret Sleeboom-Faulkner (ed.), Human Genetic Biobanks in Asia: Politics of Trust and Scientific Advancement. Routledge
Min Liu & Qingli Hu (2014). A Proposed Approach to Informed Consent for Biobanks in China. Bioethics 28 (4):181-186.
Christian Munthe (2003). The Use of Human Biobanks. Ethical, Social, Economical, and Legal Aspects: Edited by M G Hansson. Uppsala University, 2001, Free, Pp 93. ISBN 91-506-1472-X. [REVIEW] Journal of Medical Ethics 29 (2):123-a-123.
Margaret Sleeboom-Faulkner (ed.) (2009). Human Genetic Biobanks in Asia: Politics of Trust and Scientific Advancement. Routledge.
Lori B. Andrews (2005). Harnessing the Benefits of Biobanks. Journal of Law, Medicine & Ethics 33 (1):22-30.
Mats G. Hansson (2006). Combining Efficiency and Concerns About Integrity When Using Human Biobanks. Studies in History and Philosophy of Science Part C 37 (3):520-532.
Mark A. Rothstein (2005). Expanding the Ethical Analysis of Biobanks. Journal of Law, Medicine & Ethics 33 (1):89-101.
Ellen Wright Clayton (2005). Informed Consent and Biobanks. Journal of Law, Medicine & Ethics 33 (1):15-21.
Lamy I. Palmer (2005). Should Liability Play a Role in Social Control of Biobanks? Journal of Law, Medicine & Ethics 33 (1):70-78.
Added to index2010-08-24
Total downloads3 ( #447,956 of 1,707,725 )
Recent downloads (6 months)0
How can I increase my downloads?